The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Dr. Bunker will focus on leading Research and Development (R&D) in San Diego, advancing the preclinical pipeline and optimizing the Company’s Integrated Discovery Engine.
Transformation to pure-play Innovative Medicines company nears completion
The committee unanimously decided to confer the Lifetime Achievement Award to Kiran Mazumdar-Shaw for her monumental contributions as a global leader in biotechnology innovation and entrepreneurship
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Subscribe To Our Newsletter & Stay Updated
